177 related articles for article (PubMed ID: 28222663)
1. miR-29a suppresses MCF-7 cell growth by downregulating tumor necrosis factor receptor 1.
Zhao Y; Yang F; Li W; Xu C; Li L; Chen L; Liu Y; Sun P
Tumour Biol; 2017 Feb; 39(2):1010428317692264. PubMed ID: 28222663
[TBL] [Abstract][Full Text] [Related]
2. MiR-29a-3p Enhances the Viability of Rat Neuronal Cells that Injured by Oxygen-Glucose Deprivation/Reoxygenation Treatment Through Targeting TNFRSF1A and Regulating NF-κB Signaling Pathway.
Gao XZ; Zhang ZX; Han GL
J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105210. PubMed ID: 33066952
[TBL] [Abstract][Full Text] [Related]
3. Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.
Sun LL; Wang J; Zhao ZJ; Liu N; Wang AL; Ren HY; Yang F; Diao KX; Fu WN; Wan EH; Mi XY
Oncol Rep; 2014 May; 31(5):2085-92. PubMed ID: 24677135
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.
Shen H; Li L; Yang S; Wang D; Zhong S; Zhao J; Tang J
Gene; 2016 Nov; 593(1):84-90. PubMed ID: 27523474
[TBL] [Abstract][Full Text] [Related]
5. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
6. XIAP 3'-untranslated region as a ceRNA promotes FSCN1 function in inducing the progression of breast cancer by binding endogenous miR-29a-5p.
Wu Q; Yan H; Tao SQ; Wang XN; Mou L; Chen P; Cheng XW; Wu WY; Wu ZS
Oncotarget; 2017 Mar; 8(10):16784-16800. PubMed ID: 28186968
[TBL] [Abstract][Full Text] [Related]
7. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory role of Mir-29 in growth of breast cancer cells.
Wu Z; Huang X; Huang X; Zou Q; Guo Y
J Exp Clin Cancer Res; 2013 Dec; 32(1):98. PubMed ID: 24289849
[TBL] [Abstract][Full Text] [Related]
9. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.
Zhong S; Li W; Chen Z; Xu J; Zhao J
Gene; 2013 Nov; 531(1):8-14. PubMed ID: 23994196
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA LINC00662 promotes proliferation and migration of breast cancer cells via regulating the miR-497-5p/EglN2 axis.
Cheng L; Xing Z; Zhang P; Xu W
Acta Biochim Pol; 2020 Jun; 67(2):229-237. PubMed ID: 32558530
[TBL] [Abstract][Full Text] [Related]
11. miR-29a contributes to breast cancer cells epithelial-mesenchymal transition, migration, and invasion via down-regulating histone H4K20 trimethylation through directly targeting SUV420H2.
Wu Y; Shi W; Tang T; Wang Y; Yin X; Chen Y; Zhang Y; Xing Y; Shen Y; Xia T; Guo C; Pan Y; Jin L
Cell Death Dis; 2019 Feb; 10(3):176. PubMed ID: 30792382
[TBL] [Abstract][Full Text] [Related]
12. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.
Cui W; Zhang S; Shan C; Zhou L; Zhou Z
FEBS J; 2013 Aug; 280(16):3962-74. PubMed ID: 23786162
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.
Qin H; Liu W
J Cell Physiol; 2019 Apr; 234(4):3526-3537. PubMed ID: 30443946
[TBL] [Abstract][Full Text] [Related]
14. miR-29a up-regulation in AR42J cells contributes to apoptosis via targeting TNFRSF1A gene.
Fu Q; Qin T; Chen L; Liu CJ; Zhang X; Wang YZ; Hu MX; Chu HY; Zhang HW
World J Gastroenterol; 2016 May; 22(20):4881-90. PubMed ID: 27239114
[TBL] [Abstract][Full Text] [Related]
15. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
[TBL] [Abstract][Full Text] [Related]
16. LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15.
Liu Y; Cheng T; Du Y; Hu X; Xia W
BMC Mol Cell Biol; 2020 Sep; 21(1):69. PubMed ID: 32998707
[TBL] [Abstract][Full Text] [Related]
17. Silencing of hsa_circ_0004771 inhibits proliferation and induces apoptosis in breast cancer through activation of miR-653 by targeting ZEB2 signaling pathway.
Xie R; Tang J; Zhu X; Jiang H
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30979827
[No Abstract] [Full Text] [Related]
18. CircACAP2 promotes breast cancer proliferation and metastasis by targeting miR-29a/b-3p-COL5A1 axis.
Zhao B; Song X; Guan H
Life Sci; 2020 Mar; 244():117179. PubMed ID: 31863774
[TBL] [Abstract][Full Text] [Related]
19. miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3.
Li R; Liu J; Li Q; Chen G; Yu X
Tumour Biol; 2016 Mar; 37(3):3987-96. PubMed ID: 26482618
[TBL] [Abstract][Full Text] [Related]
20. Identification of direct target genes of miR-7, miR-9, miR-96, and miR-182 in the human breast cancer cell lines MCF-7 and MDA-MB-231.
Moazzeni H; Najafi A; Khani M
Mol Cell Probes; 2017 Aug; 34():45-52. PubMed ID: 28546132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
